Whilst my preference is for a juicy takeover, many, many multiples north of the $4-$5b AUD mark, I would personally be happy to see them go alone for P3. Makes no difference to me, other than to significantly improve my return.
If people don't like that approach, then presumably as we proceed people can take their money off the table at the $4-5b AUD mark as the SP appreciates over time due to milestones being met and we draw closer to go live for a drug, in an indication which we have full control of.
- Forums
- ASX - By Stock
- Share Price
Whilst my preference is for a juicy takeover, many, many...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.94 |
Change
-0.290(1.79%) |
Mkt cap ! $2.037B |
Open | High | Low | Value | Volume |
$16.33 | $16.37 | $15.78 | $10.73M | 671.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | $15.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.02 | 1422 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 15.900 |
1 | 3286 | 15.870 |
3 | 3218 | 15.850 |
1 | 1357 | 15.840 |
2 | 2146 | 15.820 |
Price($) | Vol. | No. |
---|---|---|
16.020 | 1422 | 2 |
16.040 | 1796 | 1 |
16.070 | 1796 | 1 |
16.090 | 2700 | 1 |
16.100 | 1796 | 1 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online